Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Nortiva Bio Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. Those matters are distributed among 3 distinct examiners and 3 distinct art units, indicating that the portfolio does not depend on a single examination assignment.
PEEBLES, KATHERINE is the busiest examiner, with 1 pending matter. Counsel can therefore organize prosecution by matter and examiner, while tracking the separate art-unit contexts individually.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| SONG, INJA | 1 | 66.5% | +47.7% |
| SCHMITT, MICHAEL J | 1 | 57.0% | +20.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18637281 | GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMS | SONG, INJA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18731125 | MANUFACTURING METHODS FOR GASTRIC RESIDENCE SYSTEMS | PEEBLES, KATHERINE | — |
| 18637281 | GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMS | SONG, INJA | — |
| 18289331 | GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE | SCHMITT, MICHAEL J | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 3783 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18731125 | MANUFACTURING METHODS FOR GASTRIC RESIDENCE SYSTEMS | PEEBLES, KATHERINE | 1617 | §102§103§112DP | Non-Final OA | — | Pending | May 31, 2024 |
| 18637281 | GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMS | SONG, INJA | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 16, 2024 |
| 18289331 | GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE | SCHMITT, MICHAEL J | 1629 | §103 | Non-Final OA | — | Pending | Nov 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNortiva Bio Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Katherine Peebles has the most, with 1 of Nortiva Bio Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
